<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In five head-injured patients with cerebral <z:mp ids='MP_0009275'>contusion</z:mp> and <z:hpo ids='HP_0000969'>oedema</z:hpo> in whom it was not possible to control intracranial pressure (ICP) (ICP greater than 20 mmHg) by artificial <z:hpo ids='HP_0002883'>hyperventilation</z:hpo> (PaCO2 level 3.5-4.0 kPa) and <z:chebi fb="8" ids="29745">barbiturate</z:chebi> sedation, <z:chebi fb="0" ids="49662">indomethacin</z:chebi> was used as a vasoconstrictor drug </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> patients, <z:chebi fb="0" ids="49662">indomethacin</z:chebi> (a bolus injection of 30 mg, followed by 30 mg/h for seven hours) reduced ICP below 20 mmHg for several hours </plain></SENT>
<SENT sid="2" pm="."><plain>Studies of cerebral circulation and metabolism during <z:chebi fb="0" ids="49662">indomethacin</z:chebi> treatment showed a decrease in CBF at 2 h </plain></SENT>
<SENT sid="3" pm="."><plain>After 7 h, ICP remained below 20 mmHg in three patients, and these still had reduced CBF </plain></SENT>
<SENT sid="4" pm="."><plain>In the other patients a return of ICP and CBF to pretreatment levels was observed </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> patients <z:chebi fb="0" ids="49662">indomethacin</z:chebi> treatment was followed by a fall in rectal temperature </plain></SENT>
<SENT sid="6" pm="."><plain>These results suggest that <z:chebi fb="0" ids="49662">indomethacin</z:chebi> due to its cerebral vasoconstrictor and <z:chebi fb="0" ids="35493">antipyretic</z:chebi> effect should be considered as an alternative for treatment of ICP-<z:hpo ids='HP_0000822'>hypertension</z:hpo> in head-injured patients </plain></SENT>
</text></document>